Abstract:Background The German Xenotransplantation Consortium is in the process to prepare a clinical trial application (CTA) on xenotransplantation of genetically modified pig hearts. In the CTA documents to the central and national regulatory authorities, that is, the European Medicines Agency (EMA) and the Paul Ehrlich Institute (PEI), respectively, it is required to list the potential zoonotic or xenozoonotic porcine microorganisms including porcine viruses as well as to describe methods of detection in order to prevent their transmission. The donor animals should be tested using highly sensitive detection systems. I would like to define a detection system as the complex including the actual detection methods, either PCR‐based, cell‐based, or immunological methods and their sensitivity, as well as sample generation, sample preparation, sample origin, time of sampling, and the necessary negative and positive controls. Lessons learned from the identification of porcine cytomegalovirus/porcine roseolovirus (PCMV/PRV) in the xenotransplanted heart in the recipient in the Baltimore study underline how important such systems are. The question is whether veterinary laboratories can supply such assays. Methods A total of 35 veterinary laboratories in Germany were surveyed for their ability to test for selected xenotransplantation‐relevant viruses, including PCMV/PRV, hepatitis E virus, and porcine endogenous retrovirus‐C (PERV‐C). As comparison, data from Swiss laboratories and a laboratory in the USA were analyzed. Furthermore, we assessed which viruses were screened for in clinical and preclinical trials performed until now and during screening of pig populations. Results Of the nine laboratories that provided viral diagnostics, none of these included all potential viruses of concern, indeed, the most important assays confirmed in recent human trials, antibody detection of PCMV/PRV and screening for PERV‐C were not available at all. The situation was similar in Swiss and US laboratories. Different viruses have been tested for in first clinical and preclinical trials performed in various countries. Conclusion Based on these results it is necessary to establish special virological laboratories able to test for all xenotransplantation‐relevant viruses using validated assays, optimally in the xenotransplantation centers.

Detection of porcine cytomegalovirus, a roseolovirus, in pig ovaries and follicular fluid: implications for somatic cells nuclear transfer, cloning and xenotransplantation

A transgenic Marc-145 cell line of piggyBac transposon-derived targeting shRNA interference against porcine reproductive and respiratory syndrome virus.

How, where and when to screen for porcine cytomegalovirus (PCMV) in donor pigs for xenotransplantation

Monitoring swine virus transmission in embryos derived from commercial abattoir oocytes

Targeted Integration of siRNA against Porcine Cytomegalovirus (PCMV) Enhances the Resistance of Porcine Cells to PCMV

Reduction of the survival time of pig xenotransplants by porcine cytomegalovirus

Risk of pathogenic virus transmission by somatic cell nuclear transfer: implications for xenotransplantation

Human fibroblasts are permissive for porcine cytomegalovirus in vitro

Screening for Viruses in Indigenous Greek Black Pigs

In vitro analysis of Porcine Endogenous Retroviruses in different pig cell types

Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival

Activation of cytomegalovirus in pig-to-primate organ xenotransplantation

Limited availability of methods for the detection of xenotransplantation‐relevant viruses in veterinary laboratories

Porcine endogenous retroviruses in xenotransplantation

Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation

A polymerase chain reaction-based protocol for the detection of transmission of pig endogenous retroviruses in pig to human xenotransplantation

Isolation of an Ecotropic Porcine Endogenous Retrovirus PERV-C from a Yucatan SLAD/D Inbred Miniature Swine

Monitoring for potentially xenozoonotic viruses in New Zealand pigs

Porcine Lymphotropic Herpesviruses (PLHVs) and Xenotranplantation

Analysis of potential porcine endogenous retrovirus (PERV) transmission in a whole-organ xenotransplantation model without interfering microchimerism

Factors affecting efficiency of introducing foreign DNA and RNA into parthenogenetic or in vitro-fertilized porcine eggs by cytoplasmic microinjection